argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
554.71
-6.57 (-1.17%)
At close: Jul 15, 2025, 4:00 PM
555.96
+1.25 (0.23%)
After-hours: Jul 15, 2025, 4:04 PM EDT
argenx SE Market Cap
argenx SE has a market cap or net worth of $34.18 billion as of July 15, 2025. Its market cap has increased by 29.51% in one year.
Market Cap
34.18B
Enterprise Value
30.59B
1-Year Change
29.51%
Ranking
Category
Stock Price
$554.71
Market Cap Chart
Since May 18, 2017, argenx SE's market cap has increased from $618.00M to $34.18B, an increase of 5,431.00%. That is a compound annual growth rate of 63.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 34.10B | -7.26% |
| Dec 31, 2024 | 36.77B | 72.75% |
| Dec 29, 2023 | 21.29B | 2.05% |
| Dec 30, 2022 | 20.86B | 15.89% |
| Dec 31, 2021 | 18.00B | 29.92% |
| Dec 31, 2020 | 13.85B | 126.49% |
| Dec 31, 2019 | 6.12B | 96.21% |
| Dec 31, 2018 | 3.12B | 83.75% |
| Dec 29, 2017 | 1.70B | 174.53% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.60B |
| Johnson & Johnson | 377.32B |
| AbbVie | 338.30B |
| Novo Nordisk | 308.09B |
| UnitedHealth Group | 272.67B |
| Novartis AG | 237.08B |
| Abbott Laboratories | 229.71B |
| AstraZeneca | 222.35B |